Aclaris Therapeutics, Inc. Active Patents
17 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-11-08: Application 18504778; Invention ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS; Applicant ACLARIS THERAPEUTICS, INC.; Status Patented Case.
- 2023-10-24: Application 18383301; Invention PYRROLOPYRIMIDINE ITK INHIBITORS; Applicant ACLARIS THERAPEUTICS, INC.; Status Patented Case.
- 2023-08-10: Application 18232651; Invention METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS; Applicant ACLARIS THERAPEUTICS, INC.; Status Patented Case.
- 2023-07-03: Application 18217874; Invention SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME; Applicant ACLARIS THERAPEUTICS, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-08 | 18504778 | ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2025-07-29 | 12370195 | US20240197732A1 | Walter SMITH Joseph MONAHAN Edward HELLRIEGEL David GORDON Heidi HOPE John Robert SPRINGER Gary A. DECRESCENZO | United States United States United States United States United States United States United States | WARD, PAUL V |
| 2023-10-24 | 18383301 | PYRROLOPYRIMIDINE ITK INHIBITORS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2025-05-13 | 12297203 | US20240132505A1 | Eric Jon JACOBSEN David Randolph ANDERSON James Robert BLINN Susan Landis HOCKERMAN Richard HEIER Paramita MUKHERJEE | United States United States United States United States United States United States | WARD, PAUL V |
| 2023-08-10 | 18232651 | METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2025-08-12 | 12384757 | US20240043398A1 | Gary A. DECRESCENZO John Robert SPRINGER | United States United States | ABDALHAMEED, MANAHIL MIRGHANI ALI |
| 2023-07-03 | 18217874 | SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME | ACLARIS THERAPEUTICS, INC. | Patented Case | 2025-04-22 | 12281111 | US20240067643A1 | David Randolph ANDERSON Susan Landis HOCKERMAN James Robert BLINN Eric Jon JACOBSEN | United States United States United States United States | KENYON, JOHN S |
| 2022-09-27 | 17907514 | CRYSTALLINE FORMS OF (P)-3-CHLORO-4-((3,5-DIFLUOROPYRIDIN-2-YL)METHOXY)-2'-(2-(2-HYDROXYPROPAN-2-YL)PYRIMIDIN-4-YL)-5',6-DIMETHYL-2H-[1,4'-BIPYRIDIN]-2-ONE | ACLARIS THERAPEUTICS, INC. | Patented Case | 2026-05-05 | 12616696 | US20230242505A1 | Gary A. DECRESCENZO John Robert SPRINGER Susan Landis HOCKERMAN | United States United States United States | WILLIS, DOUGLAS M |
| 2022-01-26 | 17630414 | DEUTERATED MK2 PATHWAY INHIBITORS AND METHODS OF USING THE SAME | ACLARIS THERAPEUTICS, INC. | Patented Case | 2025-09-02 | 12403141 | US20220288070A1 | David Randolph ANDERSON Gary Anthony DECRESCENZO | United States United States | BAUER, NICOLA MARIA |
| 2021-11-23 | 17533931 | METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2023-09-26 | 11767309 | US20220235025A1 | Gary A. DECRESCENZO John Robert SPRINGER | United States United States | ABDALHAMEED, MANAHIL MIRGHANI ALI |
| 2021-04-21 | 17236531 | PYRROLOPYRIMIDINE ITK INHIBITORS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2023-11-21 | 11820775 | US20220348579A1 | Eric Jon JACOBSEN David Randolph ANDERSON James Robert BLINN Susan Landis HOCKERMAN Richard HEIER Paramita MUKHERJEE | United States United States United States United States United States United States | WARD, PAUL V |
| 2021-03-26 | 17214532 | ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2023-12-19 | 11844801 | US20210338669A1 | Walter SMITH Joseph MONAHAN Edward HELLRIEGEL David GORDON Heidi HOPE John Robert SPRINGER Gary A. DECRESCENZO | United States United States United States United States United States United States United States | WARD, PAUL V |
| 2021-03-16 | 17203482 | SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME | ACLARIS THERAPEUTICS, INC. | Patented Case | 2023-08-29 | 11739086 | US20210284637A1 | David Randolph ANDERSON Susan Landis HOCKERMAN James Robert BLINN Eric Jon JACOBSEN | United States United States United States United States | KENYON, JOHN S |
| 2019-08-12 | 16538354 | PYRROLOPYRIMIDINE ITK INHIBITORS | ACLARIS THERAPEUTICS, INC. | Patented Case | 2021-06-01 | 11021482 | US20200048262A1 | Eric Jon JACOBSEN David Randolph ANDERSON James Robert BLINN Susan Landis HOCKERMAN Richard HEIER Paramita MUKHERJEE | United States United States United States United States United States United States | WARD, PAUL V |
| 2018-11-02 | 16179695 | SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME | ACLARIS THERAPEUTICS, INC. | Patented Case | 2021-04-20 | 10981906 | US20190135808A1 | David Randolph ANDERSON Susan Landis HOCKERMAN James Robert BLINN Eric Jon JACOBSEN | United States United States United States United States | KENYON, JOHN S |
| 2018-05-21 | 15984918 | STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES | ACLARIS THERAPEUTICS, INC. | Patented Case | 2019-07-02 | 10335391 | US20180263962A1 | Pramod Sarpotdar Kevin Warner Steven Zhang Gurpreet Ahluwalia Amy Kuang | United States United States United States United States United States | SHIAO, REI TSANG |
| 2018-01-25 | 15880385 | PYRROLOPYRIMIDINE ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER | ACLARIS THERAPEUTICS, INC. | Patented Case | 2019-06-11 | 10316038 | US20180208594A1 | Eric Jon Jacobsen James Robert Blinn John Robert Springer Susan Landis Hockerman David Randolph Anderson | United States United States United States United States United States | RAHMANI, NILOOFAR |
| 2017-05-31 | 15609876 | HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER | ACLARIS THERAPEUTICS, INC. | Patented Case | 2018-12-11 | 10150783 | US20170260211A1 | Eric Jon JACOBSEN James Robert BLINN John Robert SPRINGER Susan L. HOCKERMAN | United States United States United States United States | CARCANAGUE, DANIEL R |
| 2015-08-07 | 14821396 | METHYL/ | ACLARIS THERAPEUTICS, INC. | Patented Case | 2017-05-02 | 9636333 | US20150352092A1 | Susan L. Hockerman Joseph B. Monahan Shaun R. Selness | United States United States United States | RAO, DEEPAK R |
| 2015-06-11 | 14737360 | STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES | ACLARIS THERAPEUTICS, INC. | Patented Case | 2017-10-31 | 9801857 | US20150359781A1 | Pramod Sarpotdar Kevin Warner Steven Zhang Gurpreet Ahluwalia Amy Kuang | United States United States United States United States United States | SHIAO, REI TSANG |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |